Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Aspire Biopharma Holdings ( (ASBP) ) is now available.
Aspire Biopharma Holdings, Inc. received notifications from Nasdaq on April 16, 2025, regarding noncompliance with listing rules due to its market value and bid price falling below required levels for 30 consecutive days. The company failed to rectify these deficiencies within the given 180-day compliance period, leading to a potential delisting notice on October 15, 2025. Aspire Biopharma has requested a hearing to present its compliance plan and seek an extension, although there is no guarantee of success.
More about Aspire Biopharma Holdings
Aspire Biopharma Holdings, Inc. operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative therapies.
Average Trading Volume: 21,977,383
Technical Sentiment Signal: Sell
Current Market Cap: $15.82M
Find detailed analytics on ASBP stock on TipRanks’ Stock Analysis page.